← Statins × cardiovascular events

Observational studyJournal of the American Heart Association2019

Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement.

Poghni A Peri-Okonny et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 3,956 people · 2019

Not counted

Reduced cardiovascular events

−35%−51% to −13%

Bigger than 8 in 10 for cardiovascular events

As reported

HR 0.65, 95% CI 0.49–0.87

Not counted

Reduced cardiovascular events

−34%−54% to −4%

Bigger than 8 in 10 for cardiovascular events

As reported

HR 0.66, 95% CI 0.46–0.96

Not counted

Reduced cardiovascular events

−36%−56% to −1%

Bigger than 8 in 10 for cardiovascular events

As reported

HR 0.64, 95% CI 0.44–0.99

Three numbers in the abstract

the abstract, start to end

… risk of all-cause (hazard ratio [HR] 0.65, 95% CI 0.49-0.87, P=0.001), cardiovascular (HR 0.66, 95% CI 0.46-0.96, P=0.030), and noncardiovascular mortality (HR 0.64, 95% CI 0.44-0.99, P=0.045) …

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.650.49–0.87
Cardiovascular events
HR 0.660.46–0.96
Cardiovascular events
HR 0.640.44–0.99
StatinsCardiovascular events
1 / 3

10 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30947591